Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Leukemia, Myeloid, Acute 34Leukemia 10Congenital Abnormalities 5Recurrence 4Leukemia, Monocytic, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Leukemia, Myelomonocytic, Acute 3Hematologic Neoplasms 3Burkitt Lymphoma 3Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Sarcoma, Myeloid 1Sarcoma, Kaposi 1Sarcoma 1Neoplasms 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Leukemia, Eosinophilic, Acute 1Leukemia, Basophilic, Acute 1Chromosome Aberrations 1Breast Neoplasms 1Acute Myeloid Leukemia With KMT2A Rearrangement 1AIDS-related Kaposi sarcoma 1

Interventions

Paclitaxel 81Trastuzumab 76Fulvestrant 55Cyclophosphamide 49Capecitabine 42Lapatinib 40pembrolizumab 39Docetaxel 38palbociclib 36Carboplatin 33Letrozole 28olaparib 23Doxorubicin 23Gemcitabine 21Taxes 20Everolimus 20ribociclib 19abemaciclib 19Ado-Trastuzumab Emtansine 18pertuzumab 17Radiotherapy 17Magnetic Resonance Spectroscopy 17Bevacizumab 16130-nm albumin-bound paclitaxel 16exemestane 15Vinorelbine 15Cisplatin 15veliparib 14Biopsy 14Alpelisib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Breast Neoplasms × Daunorubicin × Clear all
NCT00004207 2014-06-24

Liposomal Daunorubicin in Treating Patients With Metastatic Breast Cancer

National Cancer Institute (NCI)

Phase 1 Unknown
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡